Volume 22, Issue 12 pp. 1727-1730
Case of the Month

Lambert–Eaton myasthenic syndrome with ophthalmoparesis and pseudoblepharospasm

Naomi Kanzato MD

Corresponding Author

Naomi Kanzato MD

Department of Neurology, National Okinawa Hospital, Ganeko 3-20-14, Ginowan-shi, Okinawa 901-2214, Japan

Department of Neurology, National Okinawa Hospital, Ganeko 3-20-14, Ginowan-shi, Okinawa 901-2214, JapanSearch for more papers by this author
Masakatsu Motomura MD

Masakatsu Motomura MD

Third Department of Internal Medicine, Kagoshima University, Kagoshima, Japan

Search for more papers by this author
Masahito Suehara MD

Masahito Suehara MD

Department of Neurology, National Okinawa Hospital, Ganeko 3-20-14, Ginowan-shi, Okinawa 901-2214, Japan

Search for more papers by this author
Kimiyosi Arimura MD

Kimiyosi Arimura MD

First Department of Internal Medicine, Nagasaki University, Nagasaki, Japan

Search for more papers by this author

Abstract

We report a patient initially diagnosed as having ocular myasthenia gravis who showed progressive ophthalmoparesis and pseudoblepharospasm together with positive acetylcholine receptor antibodies. Repeated evaluation with high-frequency repetitive stimulation revealed an incremental response and elevated titers of antibodies against presynaptic calcium channels, confirming Lambert–Eaton myasthenic syndrome. Systemic evaluation revealed no malignant neoplasm but revealed euthyroid Hashimoto's disease. Immunomodulative therapy including plasma exchange and administration of an immunosuppressent (azathioprine) combined with a potassium-channel blocker (3,4-diaminopyridine) reduced the ocular abnormalities. We conclude that the ocular manifestations in this patient were probably caused by Lambert–Eaton myasthenic syndrome. © 1999 John Wiley & Sons, Inc. Muscle Nerve 22: 1727–1730, 1999

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me